Using logistic regression, we analyzed the predictive value of a number of entry variables with respect to the outcome variables delayed cerebral ischemia, rebleeding, and poor outcome (death or severe disability) in patients with aneurysmal subarachnoid hemorrhage. The entry variables were clinical condition on admission (grades on the Glasgow Coma Scale, Hunt and Hess system), the amount of subarachnoid and intraventricular blood and the presence of hydrocephalus on the admission computed tomogram, and antifibrinolytic treatment with tranexamic acid. We used data from a prospectively studied population of 176 patients admitted within 72 hours after subarachnoid hemorrhage. The risk of delayed cerebral ischemia was best predicted by the amount of subarachnoid blood, intraventricular blood, and antifibrinolytic treatment irrespective of clinical condition and hydrocephalus. The site of delayed cerebral ischemia was not related to the location of the subarachnoid hemorrhage. Antifibrinolytic treatment was the only entry variable (negatively) predicting the risk of rebleeding. Death or severe disability after 3 months was best predicted by the amount of subarachnoid blood and the initial clinical condition reflected by the grade on the Glasgow Coma Scale.
T he complications delayed cerebral ischemia
(DCI) and rebleeding after aneurysmal subarachnoid hemorrhage (SAH) are the most important causes of death and disability in both surgical and nonsurgical patients with ruptured aneurysms. 12 Early prediction of these complications could be important in the management of such patients and in the evaluation of new treatments. It has been recognized for a long time that the initial clinical condition of the patient, especially the level of consciousness, is related to the eventual outcome. 34 An increased incidence of rebleeding in patients with poor initial clinical condition has been reported, 5 -7 but we could not confirm this relation when strict criteria for the diagnosis of rebleeding were applied. 8 In poor-grade patients we found an increased incidence of DCI and other intracranial complications, which may determine poor outcome.
In recent studies, the amount of subarachnoid blood on an early computed tomogram (CT scan) proved to have predictive value with regard to DCI. 9 - 15 Increased incidence of DCI was also found in patients with acute hydrocephalus, 1617 which in turn was more strongly related to the amount of intraventricular than to the amount of subarachnoid blood.
Since the initial clinical condition of the patient, the presence of large amounts of subarachnoid and intraventricular blood, and ventricular dilatation may be interdependent, it remains to be established whether all these variables have independent predictive value regarding DCI, rebleeding, and death or severe disability. We investigated this problem prospectively in 176 patients with SAH, using strict criteria for the clinical diagnosis of DCI and rebleeding.
Subjects and Methods
From October 1977 to January 1983, we conducted a randomized controlled trial to test the effect of the antifibrinolytic agent tranexamic acid (TEA) in patients with SAH. 18 From a total of 264 patients admitted during that period, 176 were eligible for our trial; the other patients were excluded because of imminent death in 32, because >72 hours had elapsed between SAH and admission in 53, or because of contraindications for antifi- All 176 trial patients were studied prospectively and were followed for 4 weeks or until surgery or death. Eighty-eight patients received antifibrinolytic treatment with intravenous TEA, 6 g/day for the first week and 4 g/day for the next 3 weeks, or until surgery if it took place within 4 weeks. 18 The other 88 patients received placebo treatment in a similar fashion, by random allocation. For patients who were considered suitable, surgery was planned for the end of the second week; 114 patients were HYDR, presence of hydrocephalus; IVB, amount of intraventricular blood; SAB, amount of subarachnoid blood; GCS, grade on Glasgow Coma Scale; H + H, grade on Hunt and Hess grading system; TEA, antifibrinolytic treatment with tranexamic acid.
•Significant at p<0.05.
not operated on because of poor clinical condition or age of >65 years. All 176 trial patients were under continuous observation in an intensive care unit. Every clinical deterioration was reported to one of us and was analyzed.
Entry Variables
The clinical condition on admission of each patient was graded using both the Glasgow Coma Scale (GCS) 20 and the Hunt and Hess grading system (without modification for vasospasm and/or systemic disease; H + H). 4 CT was performed on admission and was repeated weekly and after every clinical deterioration. The amount of subarachnoid blood on CT was scored semiquantitatively as the sum of the scores from 0 to 3 for each of 10 cisterns. A score of 0 indicated no blood, 1 was given when blood was barely visible, 2 when an intermediate change was seen, and a score of 3 was assigned when the cistern or fissure was completely filled with blood, judged from the extent and intensity of density changes. The 10 cisterns were the frontal interhemispheric fissure, the quadrigeminal cistern, both suprasellar cisterns, both ambient cisterns, both basal sylvian fissures, and both lateral sylvian fissures. The amount of intraventricular blood was the sum of the separate scores for each of the four ventricles: 0, no blood; 1, sedimentation of erythrocytes in the posterior part; 2, ventricle partly filled with blood; and 3, ventricle completely filled with blood. Three of the authors separately scored all the admission CT scans in this manner. Differences in judgment were settled by majority vote or, in the few cases in which this was not possible, by joint review.
Hydrocephalus was judged as present or absent, and its presence was defined as a bicaudate index above the 95th percentile for age.
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Antifibrinolytic treatment is described above.
Outcome Variables
DCI was diagnosed if there were new focal signs or a decrease in the level of consciousness or both and if CT after admission showed a hypodense lesion compatible with the clinical signs or at least no lesions other than ischemia or infarction that could explain the signs. The interval between angiography (if performed) and the occurrence of clinical signs of DCI was too long in most patients to assess the contribution of vasospasm to the clinical signs.
Rebleeding was diagnosed when an increase in the amount of subarachnoid, intracerebral, or intraventricular blood could be demonstrated by CT after admission or at autopsy compared with the admission CT scan.
Death or severe disability was assessed 3 months after the aneurysmal rupture and was graded using the five-point Glasgow Outcome Scale. 23 
Analysis
For statistical analysis of the interdependence of the entry variables we used Pearson's correlation coefficient, and for analysis of single variables we used the x 2 test. The entry variables with more than two categories were dichotomized, GCS and H + H into categories with and without a considerable decrease in the level of consciousness (<12 points and Grade 3 or worse, respectively) and the amounts of subarachnoid and intraventricular blood according to the largest difference in the incidence of DCI that could be found between two categories.
For analysis of the predictive value of all entry variables combined we used step-wise logistic regression. 24 In the calculations for this model we entered hydrocephalus and antifibrinolytic treatment as present (1) or absent (0), and for the other entry variables we used the full range of their scales (GCS 3-14, H + H 1-5, subarachnoid blood 0-30, intraventricular blood 0-12). Because the predictive value of the amounts of subarachnoid and intraventricular blood may be influenced by the time between SAH and the admission CT scan from which the scores are derived," we included the day of CT scanning and the interaction variables day x subarachnoid blood and day x intraventricular blood in the analysis. The maximum interval was 3 days.
We also studied the relation between the location of subarachnoid blood on admission and the site of DCI in the patients in whom ischemic lesions could be demonstrated on later CT or at autopsy. Subarachnoid blood scores of left and right paired cisterns were added, compared, and classified as right or left when a difference of > 1 point was found and as symmetric when no such difference existed. Sites of DCI were classified as left, right, and symmetric when lesions were demonstrated in the left, right, or both hemispheres, respectively.
Results

Entry Variables
The distribution of the six entry variables in our study population is presented in Table 1 . The interdependence of the variables is presented as a correlation matrix in Table 2 . Presence of hydrocephalus and the amount of intraventricular blood are more strongly related to the initial clinical condition (GCS and H + H) than is the amount of subarachnoid blood. Furthermore, the correlation between the presence of hydrocephalus and the amount of intraventricular blood is much stronger than that between hydrocephalus and subarachnoid blood, as we have demonstrated. 16 Antifibrinolytic treatment with TEA, which was allocated randomly, is of course not related to any other entry variable.
Outcome Variables
DCI occurred in 57 patients (32%); the clinical features included hemispheric focal signs in 13, decrease in level of consciousness in 14, or both in 30. Forty-seven patients had radiolucent areas on CT after the appearance of clinical signs, in six patients the diagnosis was confirmed at autopsy, in three patients who recovered serial CT demonstrated no abnormalities, and in one patient artifacts on CT made diagnosis impossible. In these last four patients the diagnosis was made solely on clinical grounds. Thirty-eight of the 57 patients died, 21 from brain swelling and herniation and 17 from other complications. The clinical and anatomic features have been described in detail. The frequency of DCI relative to the entry variables is presented in Table 3 . The probability values in Table 3 should be interpreted with caution since the tests are not independent and since several entry variables are significantly correlated with each other (see Table 2 ). The incidence of DCI was not significantly different between patients with and without antifibrinolytic treatment, but in a larger group of patients (including those described here) the difference was significant. 18 The step-wise logistic regression model is presented in Table 4 . The probability of DCI according to this model can be calculated by entering 1 or 0 for antifibrinolytic treatment and the actual subarachnoid and intraventricular blood scores. According to the model, the amount of subarachnoid blood was the most significant factor (p = 0.0008) followed by intraventricular blood (p = 0.010) and antifibrinolytic treatment (p = 0.090).
To explore how well the model fit the data from which it was derived, we calculated the risk of DCI for each of the 176 trial patients, ranked them according to these calculated risks, and then divided this list into five consecutive groups of approximately equal size. In each group, the number of patients expected to have DCI was calculated by adding the risks of the individual patients within the group. Expected and observed frequencies in each group were then compared (Table 5 ). The relation between the location of subarachnoid blood on admission and the site of DCI in the 53 patients in whom such lesions could be demonstrated by later CT or at autopsy is presented in Table 6 . Obviously, the site of DCI is not significantly related to the location of subarachnoid blood.
Rebleeding occurred in 39 patients (22%). The clinical and anatomic features have been described. 26 The only entry variable significantly related to the frequency of rebleeding was antifibrinolytic treatment (Table 3) , and antifibrinolytic treatment was also the only entry variable that proved to have predictive value in the logistic regression model.
Death or survival in a persistent vegetative state or with severe disability (Glasgow Outcome Scale grades 1-3 23 ) occurred in 107 patients (61%) and was significantly related to a number of entry variables (Table 3) .
Step-wise logistic regression resulted in the model presented in Table 7 . The amount of subarachnoid blood was the most significant factor (p = 0.0001), even more significant than the grade on the GCS (p = 0.0030). We studied the relation between the expected and the observed outcomes as for the DCI model. The results are presented in Table 8 .
Discussion
The most important entry variable predictive of the risk of DCI proved to be the amount of subarachnoid blood on CT within 72 hours after aneurysm rupture; the next most important entry variable was the amount of intraventricular blood. Antifibrinolytic treatment with TEA also predicted risk. The predictive power of these entry variables together could not be improved further by taking into account hydrocephalus and the patients' initial clinical condition. The only entry variable that significantly predicted the frequency of rebleeding was antifibrinolytic treatment. Death or severe disability was best predicted by the entry variables amount of subarachnoid blood on CT and grade on the GCS. The former was a better predictor than the latter, but it should be kept in mind that our model was derived from patients who had survived the first 24 hours after SAH and that some early deaths included patients with moderate amounts of subarachnoid blood. 27 For practical reasons, we did not use angiographic criteria to diagnose DCI. The finding of ischemic lesions on CT in 94% of our patients and no lesions in the remaining 6% attests to the fact that they deteriorated from ischemia and not from other intracranial complications. Ischemia may be caused by mechanisms other than vasospasm, 28 but the latter is the most common cause of DCI. 29 We therefore believe that our findings apply to patients with symptomatic vasospasm after SAH.
The relation between the amount of subarachnoid blood on an early CT scan and clinical signs of DCI and ischemic lesions on a later CT scan has been demonstrated by several investigators. 9 - 15 In a prospective study of 41 patients by Kistler and coworkers, 11 86% of the patients with "severe significant clot or thick layer of subarachnoid blood" had clinical signs of ischemia compared with clinical signs in only 11% of patients with "diffuse subarachnoid blood or no blood." The authors stated that all false-positive and false-negative cases could be explained by inadequate CT technique, which suggests that a perfect correlation would exist between large amounts of subarachnoid blood and DCI. Most other studies, however, did not find such a high incidence of DCI in their patients with the largest amounts of subarachnoid blood on CT. In series that sufficiently describe criteria for the clinical diagnosis of DCI, it occurred in 51-63%. 1213 Fourteen of our patients had near-maximal subarachnoid blood scores (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) and eight of the 14 developed DCI (57%).
Because it is assumed that the relation between the amount of subarachnoid blood and DCI can be explained by the spasmogenic properties of blood clots in the subarachnoid space 3031 and because our method of summed scoring ignores the importance of localized accumulations of blood, the sensitivity of our method might be low. To investigate this, we selected patients with one or more cisterns scored 3 against a total subarachnoid blood score of slO. Seven of 19 such patients developed DCI (37%), whereas DCI occurred in 50 of the remaining 157 patients (31%). This difference is not significant; therefore, we do not believe that our method underestimates the strength of the relation between the amount of subarachnoid blood and DCI.
In only 19 of 53 patients (36%) with demonstrated ischemic lesions did we find a relation between the location of subarachnoid blood on admission and the site of the DCI lesion (Table 6 ). This relation existed in four of the seven patients (57%) with one or more cisterns scored 3 and a total subarachnoid blood score of slO (localized large clot). But in the average patient the site of DCI is much more difficult to predict as such localized large clots occurred in only 19 of 176 patients (11%), of whom only seven developed DCI. Furthermore, in many patients DCI is a multifocal or diffuse process. 25 The contribution of intraventricular blood to the risk of DCI has not been found before. In a previous study we demonstrated a relation between acute hydrocephalus and the risk of DCI, and acute hydrocephalus occurred more frequently in patients with large amounts of intraventricular blood. 16 The correlation between acute hydrocephalus and DCI has since been confirmed by others, although with less strict criteria. 17 The correlation matrix (Table 2) shows that intraventricular blood is more strongly related to both hydrocephalus and initial clinical condition than is subarachnoid blood. This may also explain why addition of clinical condition at admission and hydrocephalus do not further improve the predictive value of the logistic model. The timing of CT scanning did not modify the predictive value of the model. This is not surprising since our patients were all investigated within 3 days after SAH and since in most patients the blood begins to clear only after this period. 32 The fact that no entry variable other than antifibrinolytic treatment with TEA 18 was related to rebleeding is at variance with a number of reports in which the frequency of rebleeding was increased in poor-grade patients. 5 -7 A plausible interpretation of this difference is that in previous studies the criteria for the diagnosis of rebleeding were insufficient or lacking.
DCI is an important determinant of poor outcome and it is therefore not surprising that the amount of subarachnoid blood has predictive value with regard to outcome. The improvement of prediction by also considering the level of consciousness at admission as the grade on the GCS might be explained by the fact that poor-grade patients also have significantly more intracranial complications other than DCI (hydrocephalus, edema around a hematoma, and epilepsy) than do patients in good condition. 8 The logistic regression models for the prediction of DCI and death or severe disability fit the data from which they were derived very well (Tables 5 and 8) . Their general validity, however, has to be tested in an independent population of patients with SAH. 33 The correlations we demonstrated, of course, do not necessarily indicate causal sequences. The role of subarachnoid blood in the pathophysiology of DCI has been extensively discussed in recent reviews. 30 - 31 The contribution of intraventricular blood to the risk of DCI could be explained as follows: Intraventricular blood obstructs intraventricular cerebrospinal fluid circulation, bringing about ventricular dilatation; ventricular dilatation may impair blood flow in the microcirculation. 3435 When arterial vasospasm further impairs blood flow, infarction may result. Ventricular dilatation and intraventricular hemorrhage are also related to the development of hyponatremia and a decrease in blood volume, 1636 which may further contribute to the blood flow disturbance.
That antifibrinolytic treatment may provoke DCI has been demonstrated. 1837 TEA's contribution to this risk, however, is smaller than that of subarachnoid and intraventricular blood. That a decrease in the rate of clearance of cisternal blood does not explain the increased risk of DCI has been borne out by our observation that on serial CT the clearance rate was not different between patients with and without antifibrinolytic treatment (unpublished data). An explanation might be that, with impaired blood flow in the microcirculation caused by vasospasm and ventricular dilatation, the balance between fibrin formation and fibrinolysis changes in favor en fibrin formation when antifibrinolytic agents are given. Whether this will also occur if antifibrinolytic agents are given for a shorter period (4-5 days) and when adequate blood volume is maintained is currently under investigation. 38 
